Banner

Archive for the ‘Ticker’ Category

3D Signatures Sells 2M Shares to ScreenCell for C$500K

Icon Written by ScreenCell on October 4, 2017 – 11:44 am

3D Signatures Sells 2M Shares to ScreenCell for C$500K Oct 04, 2017   NEW YORK (GenomeWeb) – Personalized medicine company 3D Signatures announced late yesterday that it has sold 2 million shares of its common stock in a private placement to French biotechnology company ScreenCell for gross proceeds of C$500,000 (US$400,198). 3DS is developing diagnostic […]



Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer

Icon Written by ScreenCell on October 3, 2016 – 2:50 pm

Article Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer Zhaomei Mu 1,*, Naoual Benali-Furet 2, Georges Uzan 2, Anaëlle Znaty 2, Zhong Ye 3, Carmela Paolillo 4, Chun Wang 3, Laura Austin 3, Giovanna Rossi 1, Paolo Fortina 4,5, Hushan Yang 3 and Massimo Cristofanilli 1,* 1 Department of Medicine-Hematology and […]



ScreenCell Establishment Licence Canada MD class 1

Icon Written by ScreenCell on September 28, 2016 – 12:01 pm

Establishment Licence Medical Device SCRENCELL 10 Avenue Charles Péguy Centre Roger Pérez 95200 Sarcelles France This Licence is issued in accordance with the Medical Devices Regulation of Food and Drugs Act for the following activities: Manufacture Devices for Distribution: CLASS I LICENCE NUMBER: 7044                              Issue Date: 2016-06-02



Droplet Digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery

Icon Written by ScreenCell on May 30, 2016 – 4:39 pm

Droplet Digital PCR of circulating tumor cells from colorectal cancer patients can predict KRAS mutations before surgery. Jérôme Alexandre Denis1,2,3, Alexia Patroni4, Erell Guillerm1,5, Dominique Pépin2, Naoual Benali-Furet6, Janine Wechsler6, Gilles Manceau1,4, Maguy Bernard2, Florence Coulet1,5; Annette K. Larsen3, Mehdi Karoui1,4, Jean-Marc Lacorte1,2, 7 1. Sorbonne Universités, UPMC Univ. Paris 06, F-75005, Paris, France. 2. […]



SABCs 2015: Detection and Characterization of CTCs Isolated by ScreenCell® Size Exclusion Technology in Metastatic Breast Cancer

Icon Written by ScreenCell on December 10, 2015 – 4:09 pm

SABCs 2015 : Poster Session 2 – Thursday, December 10 7:30 am – 9:00 am https://www.sabcs.org/Program/Poster-Sessions/Poster-Session-2 Background: Circulating Tumor cells (CTCs) detection has prognostic and predictive implications in patients with metastatic breast cancer (MBC). Genomic and phenotypic analysis of CTCs hold enormous promise as blood-based molecular characterization and monitoring disease progression and treatment benefit with a strong […]



ASI Partners with ScreenCell to Develop a Novel, Non-Invasive Prenatal Diagnosis Based on Circulating Fetal Cells

Icon Written by ScreenCell on November 4, 2015 – 5:37 pm

November 4, 2015 ASI Partners with ScreenCell to Develop a Novel, Non-Invasive Prenatal Diagnosis Based on Circulating Fetal Cells Partnership is intended to overcome limitations of existing methods, widening the range of genetic abnormalities that can be screened. Carlsbad CA, US and Sarcelles, FRANCE – November 4, 2015 – Applied Spectral Imaging (ASI, www.spectral-imaging.com) and […]



ScreenCell sponsors Molecular Med TRI-CON 2016, March 7-9 2016, San Francisco, CA

Icon Written by ScreenCell on November 2, 2015 – 9:56 am

March 7 – 9, 2016 | Moscone North Convention Center | San Francisco, CA Part of the 23rd International Molecular Medicine Tri-Conference Circulating Tumor Cells : Enabling Liquid Biopsy Monday, March 7 1:15 Luncheon Presentation I: Size-Based Isolation of Circulating Tumor Cells Associated to Droplet Digital PCR Allow Prediction of KRAS Mutations in Patients with […]



A comparative analysis of cancer hotspot mutation profiles in circulating tumour cells, circulating tumour DNA and matched primary lung tumour

Icon Written by ScreenCell on October 9, 2015 – 11:22 am

A comparative analysis of cancer hotspot mutation profiles in circulating tumour cells, circulating tumour DNA and matched primary lung tumour Maria Leung2, Maxim Freidin1, Dasha Freidina1, Sanjay Popat3, Andrew Nicholson2, Alexandra Rice2, Angeles Montero Fernandez2, Eric Lim1,2 1National Heart and Lung Institute, Imperial College London; 2Royal Brompton Hospital, London; 3Royal Marsden Hospital, London The aim […]



Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis.

Icon Written by ScreenCell on July 2, 2015 – 2:31 pm

Circulating Tumor Cells in Diagnosing Lung Cancer: Clinical and Morphologic Analysis. Fiorelli A, Accardo M, Carelli E, Angioletti D, Santini M, Di Domenico M. Ann Thorac Surg. 2015 Jun;99(6):1899-905. doi: 10.1016/j.athoracsur.2014.11.049. Epub 2015 Feb 10. Abstract BACKGROUND: The purpose of this study was to evaluate the value of circulating non-hematologic cells to differentiate benign from […]



Circulating Tumour Cells in Patients with Malignant Lung Tumors Undergoing Radio-frequency Ablation

Icon Written by ScreenCell on July 2, 2015 – 2:25 pm

Circulating Tumour Cells in Patients with Malignant Lung Tumors Undergoing Radio-frequency Ablation. Chudasama D1, Rice A1, Anikin V1, Soppa G1, Dalal P2. Anticancer Res. 2015 May;35(5):2823-6. Abstract BACKGROUND/AIM: Radiofrequency ablation (RFA) is an increasingly utilised technique in patients with surgically-untreatable lesions. The effect of this therapy on circulating tumor cells (CTCs) is unknown. As far […]